Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free
- BOND RX™ Validated
- RabMAb
- Recombinant
- Advanced Validation
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal BMAL1 antibody. Carrier free. Suitable for ChIC/CUT&RUN-seq, IP, WB, IHC-P, ICC/IF and reacts with Human, Mouse, Rat samples. Cited in 2 publications.
View Alternative Names
ARNTL, BHLHE5, MOP3, PASD3, BMAL1, Basic helix-loop-helix ARNT-like protein 1, Aryl hydrocarbon receptor nuclear translocator-like protein 1, Basic-helix-loop-helix-PAS protein MOP3, Brain and muscle ARNT-like 1, Class E basic helix-loop-helix protein 5, Member of PAS protein 3, PAS domain-containing protein 3, bHLH-PAS protein JAP3, bHLHe5
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized PC-3 (human prostate adenocarcinoma epithelial cell) labeling BMAL1 with ab230822 at 1/100 dilution, followed by Goat Anti-Rabbit IgG H&L (Alexa Fluor®488) (ab150077) secondary antibody at 1/1000 dilution (green).
Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889) at 1/200 was used as a counterstain.
The nuclear counterstain is DAPI (blue).
Confocal image showing positive staining in PC-3 cell line.
Negative Control : Raji (PMID : 29230015).
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
- IP
Lab
Immunoprecipitation - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
ab230822 at 1/30 (2μg in 0.35mg lysates) immunoprecipitating BMAL1 in PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate.
Lane 1 (input) : PC-3 whole cell lysate (10μg)
Lane 2 (+) : ab230822 + PC-3 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab230822 in PC-3 whole cell lysate.
For western blotting, ab230822 at 1/1000 dilution (0.58 μg/mL) and ab131366 VeriBlot for IP (HRP) at 1/5000 was used for detection.
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
Fresh lysates were used in this IP.
The molecular weight observed is consistent with what has been described in the literature (PMID : 28332504).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
All lanes:
Immunoprecipitation - Anti-BMAL1 antibody [EPR23696-22] (<a href='/en-us/products/primary-antibodies/bmal1-antibody-epr23696-22-ab230822'>ab230822</a>)
Predicted band size: 68 kDa
Observed band size: 75 kDa
false
Exposure time: 50s
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
Immunohistochemical analysis of paraffin-embedded Mouse cardiac muscle tissue labeling BMAL1 with ab230822 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining in mouse cardiac muscle (PMID : 10760301). The section was incubated with ab230822 for 20 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Antigen retrieval was heat mediated with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
Immunohistochemical analysis of paraffin-embedded Rat pancreas tissue labeling BMAL1 with ab230822 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining in rat pancreas (PMID : 29396463). The section was incubated with ab230822 for 20 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Antigen retrieval was heat mediated with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
Immunohistochemical analysis of paraffin-embedded Mouse hippocampus tissue labeling BMAL1 with ab230822 at 1/1000 dilution followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Nuclear staining in mouse hippocampus (PMID : 20382135). The section was incubated with ab230822 for 20 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Antigen retrieval was heat mediated with Citrate buffer (pH 6.0, epitope retrieval solution 1) for 20 mins.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
- IP
Lab
Immunoprecipitation - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
ab230822 at 1/30 (2μg in 0.35mg lysates) immunoprecipitating BMAL1 in NIH/3T3 (mouse embryonic fibroblast) whole cell lysate.
Lane 1 (input) : NIH/3T3 whole cell lysate (10μg)
Lane 2 (+) : ab230822 + NIH/3T3 whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab230822 in NIH/3T3 whole cell lysate.
For western blotting, ab230822 at 1/1000 dilution (0.58 μg/mL) and ab131366 VeriBlot for IP (HRP) at 1/5000 was used for detection.
Blocking/Diluting buffer and concentration : 5% NFDM/TBST.
Fresh lysates were used in this IP.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
All lanes:
Immunoprecipitation - Anti-BMAL1 antibody [EPR23696-22] (<a href='/en-us/products/primary-antibodies/bmal1-antibody-epr23696-22-ab230822'>ab230822</a>)
Predicted band size: 68 kDa
Observed band size: 75 kDa
false
Exposure time: 50s
- WB
Lab
Western blot - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
This data was developed using ab230822, the same antibody clone in a different buffer formulation.
Western blot : Rabbit monoclonal [EPR23696-22] to BMAL1 ab230822 staining at 1/500 dilution, shown in green; Mouse anti GAPDH (ab8245) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 69-75 kDa in Wild-type MCF7 cell lysates with no signal observed at this size in ARNTL knockout MCF7 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-BMAL1 antibody [EPR23696-22] (<a href='/en-us/products/primary-antibodies/bmal1-antibody-epr23696-22-ab230822'>ab230822</a>) at 1/500 dilution
Lane 1:
Wild-type MCF7 at 20 µg
Lane 2:
ARNTL knockout MCF7 at 20 µg
Lane 2:
Western blot - Human ARNTL knockout MCF7 cell line (<a href='/en-us/products/cell-lines/human-arntl-knockout-mcf7-cell-line-ab289293'>ab289293</a>) at 20 µg
Lane 3:
Wild-type HeLa at 20 µg
Lane 4:
ARNTL knockout HeLa <a href='/en-us/products/cell-lines/human-arntl-bmal1-knockout-hela-cell-line-ab264701'>ab264701</a> at 20 µg
Lane 5:
Raji at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 69-75 kDa
Observed band size: 69-75 kDa
false
- WB
Lab
Western blot - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab230822).
Western blot : Rabbit monoclonal [EPR23696-22] to BMAL1 ab230822 staining at 1/500 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 69 kDa in Wild-type A549 and HeLa cell lysates with no signal observed at this size in ARNTL knockout A549 cell line and ARNTL knockout HeLa cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-BMAL1 antibody [EPR23696-22] (<a href='/en-us/products/primary-antibodies/bmal1-antibody-epr23696-22-ab230822'>ab230822</a>) at 1/500 dilution
Lane 1:
Wild-type A549 cell lysates at 20 µg
Lane 2:
Western blot - Human ARNTL knockout A549 cell line (ab288835) at 20 µg
Lane 3:
Wild-type HeLa ab255928 cell lysates at 20 µg
Lane 4:
Western blot - Human ARNTL (BMAL1) knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-arntl-bmal1-knockout-hela-cell-line-ab264701'>ab264701</a>) at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 69 kDa
Observed band size: 69 kDa
false
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
This data was developed using ab230822, the same antibody clone in a different buffer formulation.
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HepG2 (human hepatocellular carcinoma epithelial cell) cells and 5 µg of ab230822 [EPR23696-22]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
This data was developed using ab230822, the same antibody clone in a different buffer formulation.
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HepG2 (human hepatocellular carcinoma epithelial cell) cells and 5 µg of ab230822 [EPR23696-22]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
- ChIC/CUT&RUN-seq
Lab
ChIC/CUT&RUN sequencing - Anti-BMAL1 antibody [EPR23696-22] - BSA and Azide free (AB272705)
This data was developed using ab230822, the same antibody clone in a different buffer formulation.
ChIC/CUT&RUN was performed using a pAG-MNase at a final concentration of 700 ng/mL, 2.5 x 10^5 HepG2 (human hepatocellular carcinoma epithelial cell) cells and 5 µg of ab230822 [EPR23696-22]. The resulting DNA was sequenced on the Illumina NovaSeq 6000 to a depth of 10 million reads. The negative IgG control ab172730 is also shown.
The University of Geneva owns patents relevant to ChIC (Chromatin Immuno-Cleavage) methods.
Related conjugates and formulations (1)
-
Anti-BMAL1 antibody [EPR23696-22]
Reactivity data
Product details
ab272705 is the carrier-free version of ab230822.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Heliyon 10:e30240 PubMed38726105
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:640521 PubMed33790796
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com